The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning

BACKGROUND: There are no standard renal dose adjustments for melphalan conditioning for autologous stem cell transplantation (ASCT) in multiple myeloma (MM) patients. The objective of this study was to evaluate the effect of melphalan dosing and chronic kidney disease (CKD) on transplant-related out...

Descripción completa

Detalles Bibliográficos
Autores principales: Ursu, Sorana G., Maples, Samantha, Williams, Kiersten J., Patrus, Gina, Samhouri, Yazan, Fazal, Salman, Mewawalla, Prerna, Sadashiv, Santhosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627361/
https://www.ncbi.nlm.nih.gov/pubmed/37936977
http://dx.doi.org/10.14740/jh1148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627361/
https://www.ncbi.nlm.nih.gov/pubmed/37936977
http://dx.doi.org/10.14740/jh1148

Ejemplares similares